Your browser doesn't support javascript.
loading
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.
Reese, Britney; Silwal, Ashok; Daugherity, Elizabeth; Daugherity, Michael; Arabi, Mahshid; Daly, Pierce; Paterson, Yvonne; Woolford, Layton; Christie, Alana; Elias, Roy; Brugarolas, James; Wang, Tao; Karbowniczek, Magdalena; Markiewski, Maciej M.
Afiliación
  • Reese B; Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601.
  • Silwal A; Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601.
  • Daugherity E; Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601.
  • Daugherity M; Department of Engineering and Physics, Abilene Christian University, Abilene, TX 79601.
  • Arabi M; Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601.
  • Daly P; Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601.
  • Paterson Y; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Woolford L; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX 75390.
  • Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
  • Elias R; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX 75390.
  • Brugarolas J; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
  • Wang T; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX 75390.
  • Karbowniczek M; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
  • Markiewski MM; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX 75390.
J Immunol ; 205(11): 3218-3229, 2020 12 01.
Article en En | MEDLINE | ID: mdl-33158953
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas del Sistema Complemento / Carcinoma de Células Renales / Biomarcadores / Neoplasias Renales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas del Sistema Complemento / Carcinoma de Células Renales / Biomarcadores / Neoplasias Renales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos